Isotretinoin therapy and the incidence of acne relapse: A nested case-control study

British Journal of Dermatology

Volumn 160, Issue 1, 2009, Pages 217-218

  Layton, A M ^a   Dreno B ^b   Gollnick, H ^c   Mobaken, H ^d   Shear, N ^e  

^a HARROGATE AND DISTRICT NHS FOUNDATION TRUST   (United Kingdom)

^b HÔTEL DIEU   (France)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acne relapse; Isotretinoin

Indexed keywords

ISOTRETINOIN;

ACNE; DOSE RESPONSE; HUMAN; LETTER; MORBIDITY; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELAPSE; TREATMENT DURATION;

ACNE VULGARIS; CASE-CONTROL STUDIES; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ISOTRETINOIN; RECURRENCE; TREATMENT OUTCOME;

EID: 57649186578     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08935.x     Document Type: Letter

References (3)

1. Azoulay L, Oraichi D, Bérard A. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study. Br J Dermatol 2007 157 : 1240 8.
2. Ortonne JP. Oral isotretinoin treatment policy. Do we all agree? Dermatology 1997 195 (Suppl. 1 34 7.
3. Gollnick HM, Cunliffe WJ, Berson D et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003 49 (Suppl. 1 S1 37.